Skip to content

Scansource SCSC Granted (in shares)

Granted (in shares) at other companies

Repligen logo
RepligenRGEN
$125.03
Genpact logo
GenpactG
$0.00
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$10.29
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$32.52
Wingstop logo
WingstopWING
$0.00
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$34.31+175%

Other financials

Income statement

See full
Revenue$766.8M+8.8%
Gross profit$107.1M+6.9%
Operating income$23.1M+3.5%
Net income$16.9M-3.1%
EPS (diluted)$0.78+5.4%

Balance sheet

See full
Cash & equivalents$120.3M-17.8%
Total debt$115.5M-26.8%
Total equity$906.3M+0.5%
Total assets$1.8B+4.7%

Cash flow

See full
Operating cash flow$71.4M+8.0%
CapEx$2.4M+68.9%
Free cash flow$69.0M+6.7%

Valuation

See full
Market cap$1.01B+12.3%
Enterprise value$1.01B+10.4%
P/E13.8×+0.5×
P/S0.3×0.0×

Profitability

See full
Gross margin13.7%+0.2pp
Operating margin3%+0.3pp
Net margin2.4%+0.1pp
FCF margin4%-1.4pp

Returns & leverage

See full
Return on equity8.1%+0.8pp
Debt / equity0.1×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Scansource in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Scansource’s 10-K, filed August 21, 2025, on SEC EDGAR. View the filing →

Ask your AI about Scansource's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scansource's granted (in shares)?
Scansource (SCSC) reported granted (in shares) of $0.00 in Q2 2025.
What does granted (in shares) mean?
The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.